Filter posts

BIO Convention Post-Con, Plus a Look Ahead

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. …

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry

During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other …

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

As biopharmaceutical manufacturers consider the new reality of accountable care organizations (ACOs) and the impact …

BioGENEius – From Student Participant to Judge

It’s been two years since I participated as a student in BioGENEius. Last year I …

How to Drive International Innovation: Scientific American Worldview

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in …

The Affordable Care Act is Here to Stay

The Patient Protection and Affordable Care Act (ACA) of 2010 includes provisions that could lead …

Debt, Taxes and Politics: Is There a Way Out?

BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson …

Neal Carter on Ag Biotech: It's Not An Experiment Anymore

BIO International Convention attendees filled the Food & Agriculture Pavilion on the Show Floor Wednesday to …

Spotlight on China

The 20th annual BIO International Convention is wrapping up in Chicago. Experts and leaders from …

The Rise of Specialty Pharmaceuticals

Fact: Specialty pharmaceuticals represented nearly 25 percent of all drug spending last year. By 2018, …